Your browser doesn't support javascript.
loading
A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus.
Lomicová, I; Suchý, D; Pizinger, K; Cetkovská, P.
Afiliación
  • Lomicová I; Department of Dermatology and Venereology, Medical Faculty and Teaching Hospital Pilsen, Charles University, Pilsen, Czech Republic.
  • Suchý D; Department of Clinical Pharmacology, Medical Faculty and Teaching Hospital Pilsen, Charles University, Pilsen, Czech Republic.
  • Pizinger K; Department of Dermatology and Venereology, Medical Faculty and Teaching Hospital Pilsen, Charles University, Pilsen, Czech Republic.
  • Cetkovská P; Department of Dermatology and Venereology, Medical Faculty and Teaching Hospital Pilsen, Charles University, Pilsen, Czech Republic.
J Clin Pharm Ther ; 42(3): 363-366, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28191663
ABSTRACT
WHAT IS KNOWN AND

OBJECTIVE:

Drug-induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti-TNF therapies have been found to be associated with a lupus-like syndrome, which is clinically distinct from classical drug-induced as well as idiopathic lupus erythematosus. CASE DESCRIPTION We describe a case of a patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results. WHAT IS NEW AND

CONCLUSION:

Ustekinumab might be a useful treatment option for patients with a history of TNF-induced lupus-like syndrome.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adalimumab / Lupus Eritematoso Sistémico / Antiinflamatorios Límite: Adult / Female / Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adalimumab / Lupus Eritematoso Sistémico / Antiinflamatorios Límite: Adult / Female / Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: República Checa